Litcius/Paper detail

Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer

R. Vanguri, Kathleen Fenn, Matthew Kearney, Qi Wang, Hua Guo, Douglas K. Marks, Christine Chin, Claire Alcus, Julia B Thompson, Cheng‐Shiun Leu, Hanina Hibshoosh, Kevin Kalinsky, James C. Mathews, Saad Nadeem, Travis J. Hollmann, Eileen P. Connolly

2022Clinical Breast Cancer18 citationsDOIOpen Access PDF

Topics & Concepts

Breast cancerMedicineTumor microenvironmentStromal cellNeoadjuvant therapyFOXP3Immune systemOncologyCD8Hormonal therapyHormone receptorCancerTumor-infiltrating lymphocytesCancer researchInternal medicinePathologyImmunologyCancer Immunotherapy and BiomarkersBreast Cancer Treatment StudiesImmunotherapy and Immune Responses
Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer | Litcius